GE are investing in innovation for Middle East

Patients, product, price, people
and policy should be the focus
when developing healthcare
DAY 01
daily dose
26 JANUARY 2015
T h e o f f i c i a l da i ly n e w s pa p e r o f t h e ara b h e a lt h e x h i b i t i o n
Welcome to
Arab Health
Exhibition &
Congress 2015
Celebrating 40
years in healthcare
hen Arab Health began 40 years
ago, it was as a small trade show
held in tents on land right next to
the old Intercontinental Hotel in Dubai, but as
the healthcare industry has grown in the last four
decades, so has the event, evolving into one of
the world’s largest and most successful medical
shows, reflecting the increasing importance of
the Middle East as a global healthcare hub. Early
exhibitors tended to specialise in hospital supplies,
providing beds, bandages and scanning equipment,
but over time the show has seen a huge increase
in the participation of specialist groups from the
region, as well as some of the world’s most famous
teaching and training institutions, such as Cleveland
Clinic and Johns Hopkins.
For first generation exhibitors, the scale of
opportunities to meet international medical groups
and specialist companies was huge. Deals struck at
the early events fed directly into the growth of the
region’s healthcare infrastructure, supporting the
construction and supply of a number of new hospitals
built at the end of the 1970’s.The rapid expansion of
Arab Health as an exhibition and congress followed
suit and is now recognised as one of the most
important global events in the healthcare calendar.
Commenting at the event’s opening, Simon Page,
Managing Director, Informa Life Sciences Exhibitions
said: “Arab Health is at the heart of the region’s
healthcare, and for a very valid reason. With the
UAE healthcare market alone expanding by almost
100% last year and recent reports suggesting it is
on a path to becoming a AED4bn industry by 2018,
there is no better time or place to host one of the
foremost healthcare trade events in the world.”
Globally, healthcare services are struggling to
cope with a growing number of health issues. The
Gulf region in particular is facing its own fair share of
challenges with population numbers rising 5% every
year, and with residents living longer, the number of
patients living with NCD’s or chronic illness is only
going to increase.
Justin Keen the English scholar, once explained;
“No country can afford to run reactive illness
services any longer”. The way we perceive health
in the Gulf requires a cultural change, but also how
care is delivered. Despite heavy investment into
Continues on page 2
By: Thomas W. Frazier, PhD, Director, Cleveland Clinic Children’s Center for Autism
ew research out of Cleveland
Clinic Children’s Center for
Autism has focused on a genetic
subgroup of children with autism spectrum
disorder (ASD) (those with mutations of
the PTEN gene) to identify a unique pattern
of brain abnormalities and cognitive deficits.
We are now building on these insights with
new investigations that promise greater
understanding of the biological mechanisms
causing autism, and that ultimately may lead
to individualised treatments.
Disorders along the autism spectrum are frequently
debilitating and lead to lifelong impairments in social
interaction coupled with inflexible behaviour. Research
has identified a strong genetic component to autism,
but identifying effective treatments has been difficult
due to high variability in the underlying biology.
One approach to this problem is to study
genetic subgroups of autism. Our group applied this
strategy to individuals with PTEN mutations who
also have autism (PTEN-ASD). My close colleague
and scientific mentor, Charis Eng, MD, PhD,
Chair of Cleveland Clinic’s Genomic Medicine
Institute, identified the PTEN gene as a tumour
suppressor. Dr Eng also noticed that parents
with mutations in the PTEN gene were having
a disproportionately high number of children
with autism and very large heads, a feature
consistent with brain overgrowth.
Together, Dr Eng and I led a group that
recruited 17 children with PTEN-ASD (mean
age 11.5 years) and compared them to patients
Story continues on page 4
Saeed Hall
M-LNCS™ adult
adhesive sensor
Adult reusable
Stand S1H50
To learn more, visit
© 2014 Masimo. All rights reserved.
iSpO2 Rx is CE Marked. Not available in the US. Allows for use of any
M-LNCS™ sensor, sold seperately. Smart mobile device sold separately.
8631C_Ad_Arab_Health_Daily_Dose_2015_iSpO2_Rx_63x267.indd 1
12/24/14 9:26 AM
ARAB HEALTH daily dose
Welcome to Arab Health
Exhibition & Congress 2015
a new hospital infrastructure, the rise in noncommunicable and chronic diseases will not be
stopped unless the focus changes to preventing
and delaying health problems, rather than just
treating the symptoms of a poorly system, hoping
they will go away.
Healthcare experts from both clinical and
non-clinical specialities will be discussing these
issues and many others as part of the Arab Health
Congress. Regional and international speakers
are coming together to deliver the highest quality
Continuing Medical Education at 18 conferences
to an audience of more than 10,000 delegates
across the four days. The Congress, accredited by
Cleveland Clinic, is growing every year, offering
new conferences and topics on a broad spectrum
of medical specialities and disciplines. The 1st
Gulf Hypertension Conference is new this year,
running over two days offering delegates keen
to learn more about the extent of the disease
and its impact in the region. Make sure to visit
the conference registration area in the Al Wasl
Foyer between halls 4 and 5 to find out more
information about the congress and to book
your place.
To further cement Arab Health’s commitment
to further strengthen the expertise and know-how
of healthcare professionals in the region, the new
Future of Surgery Zone is a designated area in the
Plaza Hall where specialists from the healthcare
industry will conduct hands-on training sessions with
the most sophisticated and up-to-date devices.Turn
over to page 3 for the daily programme schedule.
As tradition stands, Arab Health offers its
visitors and delegates some fantastic promotional
activities during the show. Remember to register
to be in with the chance to win some great prizes,
such as the new BMW 4 Series Gran Coupe, cash
prizes and much more.
Dr. Samih Tarabichi
or only the third time in the Middle East
and again by the same doctor, a surgery
was performed recently to replace three
joints simultaneously. Dr Samih Tarabichi, Director
General of Burjeel Hospital for Advanced Surgery
and Tarabichi’s Centre of Joint Surgery, and his
team of two assistant surgeons carried out the
surgery at Burjeel Hospital for advanced Surgery.
The surgery went very well and lasted three
hours, the same time normally used to only change
a single joint.The patient is currently in rehabilitation.
“The patient flew in to the UAE with major
disabilities in both knee joints and her right hip caused
by rheumatoid arthritis. Pre-operation tests showed
that she was in a suitable condition to replace the
three joints at the same time in order to speed
up rehabilitation”, said Dr. Tarabichi, a celebrated
orthopaedic surgeon who performs more than 800
joint replacement surgeries every year.
The operation started with a bilateral total
knee replacement simultaneously using subvastus
To make the most of your visit this year, don’t
forget to download the Arab Health mobile
app from the website: http://arabhealthonline.
com/mobileapp/. The app will help you navigate
the expansive floor plans, browse through the
thousands of exhibitors and products, and
personalise your experience by creating your own
favourites and notes, all from your own device.
Thank you all for your support over the last
40 years - I wish you all the best for a successful
and prosperous four days at Arab Health 2015.
Elin Boyd
approach and Persona implants. The patient was
moved to a lateral position and a right total hip
replacement was done.
“Once the operation was over, the patient
stayed in hospital for a week to recover. We
encouraged the patient to walk from day 2
onwards”, said Dr Tarabichi. “It was necessary for
rehabilitation to start immediately post operation
to ensure optimal movement of her joints. This
rehabilitation programme will continue for two
months.” The patient is progressing well and was
discharged. She is now following up in our clinic
and physiotherapy department.
“We are pleased to have Dr Tarabichi on board, a
doctor who is constantly looking for ways to further
develop the field of orthopaedic joint surgery”,
said Dr Shajjir Gaffar, CEO of Burjeel Hospital for
Advanced Surgery in Dubai. “Constant progress in
our respective fields is an important part of our
commitment to ensuring the best medical care for
the residents of the UAE.”
Nordic study led by the Institute of
Public Health and Clinical Nutrition
at the University of Eastern Finland
discovered that the health-promoting Nordic
diet reduces the expression of inflammationassociated genes in subcutaneous adipose
tissue. In overweight persons, the expression
of these genes reduced without weight loss.
To a certain extent, it’s believed that the
adverse health effects of being overweight are
caused by an inflammatory state in adipose
tissue. The results were published in American
Journal of Clinical Nutrition.
Obesity is associated with problems in
sugar and lipid metabolism as well as with
atherosclerosis, and these may be caused by
a low-grade inflammatory state resulting from
disturbed adipose tissue function. Long-term
research into the role of diet in the function
of adipose tissue genes and inflammatory state
remains scarce.
This newly published study was part of
the Nordic SYSDIET Study. The objective was
to find out whether the health-promoting
Nordic diet affects the expression of genes
in adipose tissue without weight loss. The
study participants were middle-aged men and
women exhibiting at least two characteristics
of metabolic syndrome, such as elevated blood
pressure or fasting blood sugar levels, abnormal
blood lipid values, or at least slightly overweight.
For a period of 18-24 weeks, half of the study
participants followed the health-promoting
Nordic diet consisting of whole grain products,
vegetables, root vegetables, berries, fruit, low-fat
dairy products, rapeseed oil and three servings
of fish per week. The control group consumed
low-fibre grain products, butter-based spreads,
and had a limited intake of fish.The participants
were asked to maintain their body weight
unchanged during the intervention, and no
significant weight changes occurred during the
study period. Samples of the study participants’
adipose tissue were taken at the beginning
and end of the study, and a transcriptomics
analysis was performed in order to study the
expression of genes.
Differences in the function of as many as
128 different genes were observed in the
adipose tissue of the health-promoting Nordic
diet group and the control group. In the healthpromoting Nordic diet group, the expression
of several inflammation-associated genes was
lower than in the control group. According to
the study researchers, the fact that diet can be
used to affect the function of inflammationassociated genes without weight loss is
significant. The study sheds further light on the
significance of diet in the healing of low-grade
inflammation, which is associated with several
chronic diseases.
Visit us at Booth 4B05
enables the LED’s to move independently
of each other while adjusting the pattern
size. CFT allows the Vu to provide consistent
output on both the large and small patterns.
NUVO-strip ad-horiz.indd 1
A member of the
Medical Illumination International Group
V Series
Surgical Tables
120,000 lux
Navigator Equipment
5368 Kuhl Road • Erie, PA 16510-4703
(814) 899-4220 • Fax: (814) 899-1410
(800) 663-1152
12/9/14 12:52 PM
MONDAY 26 January 2015
Today at a glance
Arab Health 2015 Congress
Start Time
Total Radiology
Al Multaqua Ballroom
Between Halls 4 & 5
Lab Mgmt - (MEDLAB)
Sk Maktoum Hall - Part B\C
Shk Maktoum Hall
Shk Rashid Hall - Part C
Shk Rashid Hall
Shk Rashid Hall - Part D
Shk Rashid Hall
Ajman D/Fujairah A
Above Hall 7
Public Health
Dubai C&D
Above Shk Maktoum Hall
Abu Dhabi A
First floor opposite Hall 5
Quality Mgmt
Abu Dhabi B
First floor opposite Hall 5
Al Ain J & K
Above Hall 4
Exhibitor’s Dinner
19.00 at the Habtoor Grand Hotel, Dubai
Exhibitors can buy tickets today Organiser’s Office outside Hall 4. Tickets are AED100/US$25.
Transport to the Habtoor Grand Hotel is available after the show.
Arab Health Daily Dose
The Arab Health Daily Dose is the official newspaper of the
Arab Health Exhibition & Congress. Distributed Monday 26
January-Thursday 29 January 2015.
Joseph Chackola [email protected]
Elin Boyd [email protected]
Waseem Ashraf [email protected]
Mark Walls [email protected]
Zabeel Printing Press
The Arab Health Daily Dose is owned and distributed by Informa Exhibition
Life Sciences, Floor 19, World Trade Centre Tower, Dubai, UAE.
All images © unless otherwise specified.
This publication may not be reproduced or transmitted in any form in whole
or part without the written consent of the owners.
For more information on Informa Exhibitions Life Sciences publications, please
To s
k th
ing team
the h, vi rab
loc press sit us
C, a ted inofficen
Al A
e Ha
ll 3 n
Download the free Arab Health
mobile app
Arab Health 2015 is featuring the newly launched Future of Surgery Zone, which consists of a
designated area where top specialists in the healthcare sector are running hands-on training sessions
on the most sophisticated and up-to-date devices and technology. Attend absolutely free!
Visit the Future of Surgery Zone in Plaza Hall every day during Arab Health.
DAY 1 programme
 Innovation hub seminars (see schedule below)
 Interactive touchscreen displays to plan your Future of
Surgery experience
 A rare 1867 edition of medical journal, The Lancet
 A glance at the history of surgery
 Meet one on one with experts in the field
 See the 3D printed baby heart that allowed doctors
from New York- Presbyterian Morgan Stanley’s
Children’s Hospital better plan ahead of surgery on a
very complex and unique heart malformation
Depuy Joints
Stability in motion
Ahmad Kartoumah / Ahmed Ali
Primal Pictures
3D human anatomy in real-time
Ethicon Biosurgery
Advances in Surgical Haemostasis – Pipe line presentation
Health Economics
Healthcare cost drivers and medical technology
Primal Pictures
Orthopaedic surgery; a 3D resource for a 3D subject
Ethicon Bariatrics
Science of tissue management – Bariatric procedures
a Samsung
Tweet your selfie to @arab_health
along with #arabhealth
Galaxy Tab3
Upload your images at
ARAB HEALTH daily dose
merican Hospital Dubai, one of the
leading pioneers of private healthcare in
the Middle East, is set to launch its first
community clinic off-campus serving the growing
population in Dubai’s new residential communities
and business free zones.
The new clinic, strategically located in Dubai
Media City, will offer the same quality of care for
all members of the family through a dedicated
team from the American Hospital Dubai, which
has served local and regional patients from its
main campus since opening in 1996. The hospital
is announcing the new clinic today at Arab Health
2015 where the hospital is a Platinum Sponsor.
The hospital’s new Dubai Media City Clinic
(DMCC) will begin welcoming patients from 2
February 2015.
The American Hospital Dubai’s new Dubai
Media City Clinic is based on the ground floor of
the Business Central Tower, close to Sheikh Zayed
Road, offering a range of primary care services
for all members of the family, including paediatrics
and obstetrics and gynaecology, as well as imaging
(radiology, ultrasound, mammography), laboratory
(phlebotomy, draw station) and patient-only
pharmacy. The 1,420m2 clinic will have a dedicated
physician team supported by an on-site nursing
team and support staff.
The DMCC will offer close and convenient
access to high quality primary care for patients
in the nearby residential areas and business
free zones, as well as access to the American
Hospital Dubai’s full range of speciality services
and diagnostics at the main hospital campus.15
allocated parking spaces and long hours of
operation (9am-9pm, seven days) add to the
convenience. Electronic Medical Records will be
shared between the clinic and hospital campus,
for ease and speed of information sharing.
Commenting on the new clinic, American
Hospital Dubai’s CEO, Peter Makowski, said:
“American Hospital Dubai has always been
a pioneer in private healthcare and our
new Dubai Media City Clinic continues this
tradition. This major development reflects
our commitment to continue to serve the
community of Dubai within the hear t of the
community, wherever that may be. Our plan
is to take our established quality of care into
the community to meet the evolving needs of
patients in the new neighbourhoods of Dubai.
This is the first in a series of primary care clinics
that we plan to open in Dubai, as satellites to
our growing hospital campus, all delivering
the same quality of care with exper t teams of
board cer tified specialists.”
he global market for nuclear imaging
equipment, which covers Positron
and Single-Photon Emission Computed
Tomography (SPECT) systems, will expand
from US$1.83bn in 2013, at a modest
Compound Annual Growth Rate (CAGR)
of 3.3%, to reach US$2.2bn by 2020, says
research and consulting firm GlobalData.
The company’s latest repor t states that
while the US market will remain steady at
around US$1.15bn throughout the forecast
period, the country will see its global share
fall from 69% in 2013 to 53% by 2020.
Meanwhile, the Asia-Pacific (APAC) region
will see its share rise from 16% to 29% over
the same time frame.
According to Andrew S. Thompson,
PhD, GlobalData’s Senior Analyst covering
Medical Devices, a period of rapid increase
in US procedures, particularly using PET, has
led to measures to decrease the number
of procedures that can be reimbursed,
therefore reducing the demand for nuclear
imaging systems.
Thompson explains: “The economic
downturn has been a continued concern
within the entire diagnostic imaging space,
and the high cost of nuclear imaging
equipment and procedures has made this
market more susceptible to the downturn.
US nuclear imaging market growth is
heavily dependent on the replacement of
existing systems because the capacity for
new installations is limited.
“As the US economy recovers, it can be
expected that the equipment will be replaced.
However, key opinion leaders interviewed by
GlobalData reported that not all equipment
is replaced at the end of the average product
lifecycle, which will negatively impact sales.”
While the US market is likely to remain static,
with a CAGR of only 0.08% from 2014 to
2020, APAC economies, especially China
and Japan, will continue to provide immense
opportunities for increasing sales within the
global nuclear imaging arena.
Thompson continues: “Japan will see the
fastest growth over the forecast period, with
its market value more than doubling from
US$191.3mn in 2013 to US$392.1mn by
2020. “In global terms, the rising prevalence
of disease, along with an ageing and growing
population, will act as major drivers of
increased nuclear imaging use during the
forecast period.”
Continued from cover.
with autism with no known genetic cause
and to healthy controls. The primary goal was to
identify specific patterns of brain abnormalities and
thinking skills unique to PTEN-ASD.The secondary
goal was to determine whether these changes are
linked to the molecular effects of PTEN mutations.
Our study found that patients with PTEN-ASD
had overgrowth of the white matter connections
as well as spots where white matter development
was clearly abnormal. These brain changes
correlated with cognitive problems, such as
reductions in information processing speed
and memory, as well as motor difficulties in the
PTEN-ASD group relative to both other study
groups. These findings enabled us to determine
that reduction in the PTEN protein drives brain
overgrowth and white matter abnormalities
that, in turn, drive these patients’ cognitive and
behavioural impairment.
At a practical level, these data suggest that any child
presenting with large head size and developmental
or cognitive delays should receive genetic counselling
and possible testing for a PTEN mutation. Such
testing is particularly important because individuals
with PTEN-ASD may have increased cancer risks
due to the role of PTEN as a tumour suppressor and
regulator of cell growth and proliferation.
Our findings also suggest that therapists
treating patients with PTEN-ASD should speak
slowly and clearly, with frequent repetition and
attention questions, to ensure that children
understand the information being communicated.
Given the high rate of motor difficulties seen in
patients with PTEN-ASD, patients also should be
regularly referred for occupational and, in many
cases, physical therapy.
Interestingly, we did not find that other proteins
related to PTEN were abnormal, suggesting
that PTEN mutations cause reductions in PTEN
protein levels but do not seem to cause changes
in the typical PTEN biological pathways. This may
indicate that reductions in PTEN protein levels
are working through other mechanisms, such
as interactions with mitochondrial or metabolic
pathways or other noncanonical biological routes.
Future research is needed to pin down the exact
molecular effects of PTEN protein loss and develop
additional treatment targets. However, based on
the low PTEN protein levels observed in this study,
Dr Eng and I have received funding as part of a
consortium examining rare genetic causes of autism,
to longitudinally follow patients with PTEN-ASD
over two years and begin a medication trial. The
latter is especially exciting because it was designed
based on knowledge of PTEN and associated
pathways and would represent one of the first
attempts to develop an individualised gene-based
treatment approach for children with autism.
We hope to build on the findings reported
here by using processing speed, memory and brain
white matter changes as outcomes to provide
more-sensitive treatment targets than those used
in typical medication trials focused on autism
symptoms or other behavioural aspects that often
require long periods for changes to be detectable.
Ultimately, we believe this study and the
planned follow-up research are just representing
the beginning of a new paradigm for autism
research: Find the gene, or set of genes, causing
autism, comprehensively study and follow patients
with those genetic changes, and use the knowledge
gained to develop individualised treatments.
Cleveland Clinic is a sponsor of Arab Health
2015. Join Dr Frazier and other Cleveland Clinic
Children’s specialists as they present at the 8th
Middle East Paediatrics Conference.
References available on request ([email protected]
Visit the UK Pavilions
for the best in Medical Technologies
Zabeel Hall UK Medical Technologies Pavilion | Sheikh Rashid Hall UK Laboratory Technologies Pavilion
Don’t miss the UK Pavilion Surgical Simulation Demonstrations
Visit the ABHI Stand Z1D30
3828 ABHI Strip Ad 63x267.indd 1
19/01/2015 12:33
MONDAY 26 January 2015
Lord Stephen Carter CBE
Group Chief Executive, Informa plc
Stephen Carter is the Group Chief Executive of Informa PLC,
organisers of Arab Health and one of the world’s leading academic
publishing, information, knowledge and exhibitions businesses,
with a career having spanned both the Public and Private sectors.
We got a moment with Lord Carter ahead of Arab Health to
discuss Informa PLC’s role in the support of continuing education
in the life sciences industry, both regionally and internationally.
Q. How does Informa
support the life
sciences industry in
the Middle East and
Informa Life Sciences is the leading global information
partner across the healthcare and pharmaceutical
sectors. With a market capitalisation of US$5bn,
and more than 8,000 employees in 150 offices in
40 countries, Informa provides a comprehensive
range of products and services in this sector from
academic books and journals, trade magazines,
deep-knowledge databases, market intelligence,
consulting and event platforms.
Each year, across the group, we bring together
approximately 1.1 million professionals from every
corner of every continent, all looking to meet,
network and do business. The Life Sciences Global
Exhibitions division comprises of more than 20
exhibitions covering the Middle Eastern, African,
Asian and European markets.
Our academic publishing produces more than
20,000 publications and more than 5,000 titles in
life sciences and medicine. In addition to traditional
print publications, Informa provides access to
more than 8,000 titles through its award-winning
platform CRCnetBASE.
Our Business Intelligence produces a
comprehensive range of market leading news,
insights, data and analysis for business and research
professionals within the pharmaceutical and biotech
industries.We offer structured databases, subscriptionbased services, real-time news, research and businesscritical information creating business advantage.
Informa’s Knowledge and Networking division
delivers a diverse portfolio of conferences and
partnering events covers the pharmaceutical, medical
devices, biotechnology, diagnostics, fine chemicals,
agrochemicals, veterinary medicine and healthcare
arenas including market access, payers and providers.
Q. Arab Health is
Informa’s flagship
healthcare event. How
do you see the event
developing in the
coming years?
The future of exhibitions now lies in our ability to
provide a platform that offers more than just business
networking. All medical professionals have one thing
globe has taught us to never underestimate the power
of solid partnerships or mergers. For multinationals
looking to establish themselves as a big player in an
emerging market, PPPs are often the most direct way
of solidifying their brand identity in that particular
territory. Local players are more likely to understand
the local business climate and often have existing
relationships with key government departments;
something that multination’s often struggle to establish
without the endorsement of a local partner.
By acknowledging the current trends in the market
and identifying the niche opportunities available for our
exhibitors, Informa Life Sciences Exhibitions continues
to be the preferred platform for our customers to
market their products, garner intelligence, debate
industry issues and network with each other.
in common: Staying committed to life-long learning in
order to provide patients with the best possible care.
With a constant stream of new data from clinical
trials, new therapies, technology and treatments
constantly emerging, it is critical to stay current in the
real-world application of evidence-based medicine.
Each year, the Arab Health Scientific Committee
will assess the specific requirements for the region
and will develop conferences specifically designed to
cater to the requirements of the healthcare industry
in the Middle East.
Q: Are you optimistic
about the future
of the healthcare
exhibitions industry?
Retaining our competitive edge in the market and
appealing to our target audience has meant that it
has been necessary to stay up-to-date with market
fluctuations and to identify new trends in the global
healthcare industry.
We view the healthcare market in the MENA
region to be one of the most sought after markets
for healthcare investments in the world. The
healthcare market has experienced stellar growth
over the last decade and is projected to maintain its
momentum driven by a multitude of factors including
demographic growth, high and expanding medical
needs, more active investments by governments and
private sector in the healthcare market, development
of social welfare systems, introduction of private
insurance market, increased healthcare regulation,
introduction of compulsory health insurance in a
number of countries; to name a few.
Our experience running B2B exhibitions across the
Meet the team at stand S2E80 in Saeed Hall 2
during Arab Health and learn about all Informa
services, books and events.
Why should I go?
Visitors can expect to learn from
experts about the latest devices and
methods, including;
• Minimally invasive devices and
• Robotics
• Bloodless surgeries
• Laser applications
• Implantable devices and systems
• Imaging and image guiding
technologies and much more…
What does the
future of surgery
look like?
Find out by visiting the
Future of Surgery Zone in
the Plaza Hall today
Who should attend?
The Future of Surgery Zone is not
just for surgeons but is open to
anyone who’s interested in knowing
what the future entails for surgery.
What is the Future of Surgery Zone?
Who will be there?
The Future of Surgery Zone is an interactive hub
in Plaza Hall which gives you the opportunity to
learn about and experience new and exciting
surgical methods and technologies.
This is an opportunity to meet with specialists
from the leading companies listed below.
They will be showcasing their latest products
and will be available all day to answer any
questions you may have.
Participating companies:
Our futuristic
hologram doctor will
be there to welcome
you to the Plaza Hall
so be sure to stop by
and say hello.
ARAB HEALTH daily dose
By: Marwan Abedin, Chief Executive Officer, Dubai Healthcare City
n today’s fast-paced world, healthcare
systems are trying, in most cases, to remain
relevant. In the UAE, where the environment
is characteriaed by increased population, robust
infrastructure, growing prevalence of lifestyle
diseases and an increased flow of tourists, the
healthcare sector is moving at an accelerated
pace. This is further reinforced by policylevel changes like mandatory insurance and
improved healthcare delivery aimed at wellness
and preventive care.
To keep up with this pace, I believe we
need to focus on the five P’s of healthcare
development. These are:
Patients - A formidable challenge for
the UAE is to reverse the outbound medical
tourism trend. DHCC is improving healthcare
provision for residents and overseas patients
who need specialist care. As of December 2014,
over a million patient visits were recorded, 15%
of patients were medical tourists. We hope to
push this figure higher through our affiliations
with global medical tourism facilitators,
linking patients to doctors and offer medical
tourism packages including flights, visas and
accommodation for patients and their families,
and through collaborative efforts with our
stakeholders in the government.
People -
We need to address the
shortage of local healthcare talent in both
the nursing and physician professions. Towards
education and research, our dedicated academic
complex the Mohammed Bin Rashid Academic
Medical Center (MBR-AMC) is building
capacity and advancing medical education in
the region. For example, the Khalaf Ahmad Al
Habtoor Medical Simulation Center (KHMSC)
within MBR-AMC trained more than 1,400
multidisciplinary healthcare professionals in
H1 2014. We have also announced the launch
of the Mohammed Bin Rashid University of
Medicine and Health Sciences, which will offer
undergraduate and postgraduate programmes.
Product – Healthcare services can be
compared to a product.To be competitive, it must
stay relevant to meet market demands. In other
words, innovation to improve healthcare delivery;
we achieve this through strategic partnerships.
Price – We expect the phased
implementation of mandatory health insurance
in Dubai and the regulation of healthcare
insurance premiums to ensure market stability
and sustainability.
Policy – When healthcare is no
longer confined to geographical borders, a
healthcare system has to meet the challenges of
policy and regulation. Factors of accreditation,
medical visas, and follow-up care, amongst
others are all crucial.
If we manage to include all P’s in a well
thought-out formula that also takes into
consideration the latest trends in technology, I
foresee tremendous growth for the healthcare
sector in the UAE.
Marwan Abedin, Chief Executive Officer, Dubai Healthcare City
innesota International Medicine, an
international patient care management
organisation, operating in the Twin
Cities, Minnesota, USA, are sponsoring the official
opening event for the US Pavilion for the second
year in a row. The honourable US Ambassador
Barbara A. Leaf will present the US Pavilion ribbon
cutting at 11:30 today.
Minnesota International Medicine (MIM) serves
the global community by facilitating treatment
for international patients in the United States
and assisting medical communities abroad. By
building strong connections between healthcare
communities in all parts of the world, MIM strives to
create an environment that will focus on improving
healthcare for patients everywhere. MIM is the
international patient centre for top ranked medical
providers with diverse range of specialities in the
Twin Cities. International patients travelling to the
US have access to resources that will give them
a comfortable and comprehensive treatment
To learn more about MIM and their services, you
can visit their team at Arab Health, stand 1E19 in
the US Pavilion, or online at
and follow our conference experience on Twitter
MONDAY 26 January 2015
ARAB HEALTH daily dose
y 2030, almost 80% of deaths in the Middle
East will result from non-communicable
diseases (NCDs), such as cardiovascular
disease (CVD) or cancer. The high prevalence
of unhealthy diets, smoking and lack of physical
exercise, a direct result of urbanisation and rising
per capita income, are big contributing factors.
Maher Abouzeid, President and CEO of GE
Healthcare for Turkey and the Middle East, said:
“The increasing incidence of lifestyle diseases
and population growth in the GCC has caused
healthcare expenditure to increase by 10% per
year over the last five years. Total healthcare
expenditure is now expected to be more than
US$130bn in 2018. This poses a real challenge to
governments and healthcare systems in the region”
Investing 5-6% of revenues back into R&D
annually, GE remains focused on being a leader
in technology and innovation. Moreover, the
scale and rate of innovation is set to significantly
transform the sector in the next 10 years as
healthcare continues to industrialise.
“To help cater for the increase in NCDs
and to improve access to quality and affordable
healthcare, there is greater emphasis from
governments to partner with companies that can
provide system-wide solutions that deliver better
clinical and patient outcomes, one of the core
priorities of GE Healthcare”, added Abouzeid.
“It’s the 40th Arab Health, and GE Healthcare has
more than 40 years of operations in the region.
Over these past four decades, GE has been
focused on helping to deliver customer-oriented
offerings that enable caregivers to strengthen
operational efficiency, enhance diagnostic
competencies, and potentially reduce healthcare
expenditure through earlier diagnosis, better
tracking of disease progression and personalized
medicine. Many of these offerings are today at
work, helping our customers and partners bring
better care to patients across the Arab world.”
GE Healthcare has a history of pioneering
innovation. It was the first healthcare provider to
produce the world’s first x-ray fluoroscopy scan,
the first commercially available mammography
technology, the world’s first high definition CT
scanner and more recently, the first to make
available a portable 4D foetal ultrasound. GE will
continue this tradition at Arab Health by launching
several of its latest technologies developed to
improve healthcare in the Middle East.
One such innovation being introduced is the
SIGNA Pioneer Magnetic Resonance Imaging (MRI)
scanner. With MRI scans, radiologists typically have
to take several images, each one with a different
focus, to get the best look inside a patient. This is
a time and resource consuming process, but the
Image © GE Healthcare
510(k) pending SIGNA Pioneer* comes with
MAGiC (Magnetic Resonance Image Compilation),
a software platform that can actually generate
multiple contrasts from a single scan. It’s like changing
the focus of a previously taken photograph without
having to take another one. This ‘one-and-done’
imaging method means radiologists can now see
one more patient per hour, every hour, every day,
helping cater for increased demand.
GE hopes to continue its innovation in the
field of mother-and-child care in the region with
the Voluson E10 ultrasound, allowing clinicians
to view babies in the womb with amazing
detail. The system uses the same principles of
ultrasound that have been used for decades,
but the differentiator is the software. The image
processing powers of the Voluson E10 can be
used for more than superficial look at the foetus.
The technology can be used to obtain images of
the baby’s blood vessels, heart, brain and other
organs that show depth and structure in a way
that helps provide the tiny details desired. This is
especially important in the first trimester, where
it is important to keep track of the baby’s growth.
GE Healthcare is one of the largest participants
at Arab Health, with a stand larger than 525m2
in area, which has been designed to mirror the
hospital environment that customers encounter
every day, while providing insight on the innovations
that GE brings to each care setting.
Also this year, GE Healthcare is introducing
for the first time the ‘GE Arab Health’ mobile
app (available on iTunes) to help visitors navigate
their way through the new technologies GE is
presenting at Arab Health 2015. The app uses
geo-targeting to deliver content about GE’s
products and solutions to the mobile app user
based on his/her location on the stand.
As Platinum Sponsor of the event, GE
Healthcare is also extending its support to
the show conferences on Big Data, Leaders in
Healthcare, Biomed Leaders and Radiology. Visit
GE Healthcare’s pavilion at Sheikh Saeed Hall,
stand no S3B10.
References available on request ([email protected]
*SIGNA Pioneer and MAGiC are 510(k) pending
at FDA.
he Masimo iSpO2TM Rx Pulse Oximeter
for Android™ and iOS devices offers
clinicians the power of Masimo SET®
Measure-through Motion and Low Perfusion™
Pulse Oximetry in the palm of their hands, on their
smart phones and tablets.
iSpO2 Rx provides accurate spot-check and
short-term assessment of oxygen saturation
(SpO2), pulse rate (PR), and perfusion index (PI).
iSpO2 Rx is ideal for:
 Emergency workers who want the convenience
and availability of pulse oximetry at all times when
other Masimo handheld oximetry solutions are
not at hand
 Travelling respiratory therapists and physicians
who require convenient and portable solutions
Image © Masimo
 Many patients under the care of a physician for
chronic obstructive pulmonary diseases (COPD)
such as emphysema, chronic bronchitis, and
bronchiectasis, may benefit from the use of a pulse
oximeter for spot checks
 Patients under the care of a physician may use
pulse oximetry to assess the severity of an asthma
attack to help determine if a doctor or emergency
room visit is warranted.
Compact and intuitive operation with a familiar
touch-screen interface, iSpO2 Rx comes with an
integrated finger pulse oximetry sensor or an
optional M-LNCS TM connector, which allows the
iSpO2 Rx to be used with more than 20 Masimo
SET® pulse oximetry sensors.
iSpO2 Rx utilises the same Masimo SET®
Measure-through Motion and Low Perfusion™ pulse
oximetry technology proven by more than 100
independent and objective studies and used on more
than 100 million patients a year in leading hospitals
worldwide, including eight of the top 10 on the U.S.
News & World Report Best Hospitals Honor Roll (20142015). Masimo SET® pulse oximetry has been shown
to help clinicians reduce ventilator weaning time and
arterial blood gas measurements in the ICU, and
save lives and costs while reducing rapid response
activations and ICU transfers on the general floor.
iSpO2 Rx for select Android devices and iPad,
iPhone, and iPod touch also features a downloadable
and upgradeable iSpO2 Rx App, ensuring clinicians
have the latest mobile medical technologies at
their fingertips at all times. iSpO2 Rx, with real-time
display of pleth waveform with signal IQ for low
measurement confidence, can store and email up
to 12 hours of measurement history in a global
standard .CSV file format. iSpO2 Rx with the M-LNCS
connector is compatible with Masimo adhesive and
reusable sensors for paediatric and adult use.
References available on request ([email protected]
Available for purchase outside the US, the iSpO2 Rx
includes cable and sensor module (M-LNCS version
excluded), carrying case, and owner’s manual.
Android is a trademark of Google Inc. iPad, iPhone,
and iPod touch are trademarks of Apple Inc.,
registered in the US and other countries.
MONDAY 26 January 2015
By: Thomas Omogi, CEO, EMT-P, RN, Infection Control Specialist, EFP Tactical Medical Group
ass transportation and international
trade is shrinking the globe. Like never
before, people can travel across the
planet to work and interact with those from
different countries. These global interactions
improve the economies of impoverished nations,
shift international relations, and influence political
policies. This widespread interaction between
people of many countries also makes it possible for
infectious diseases to leap from one continent to
another in a matter of hours, as it did in the most
current outbreak of Ebola virus disease (EVD).
Global trade will likely spur international travel in
the future, dramatically raising the risk for infectious
diseases. Without capable emergency healthcare
management on the part of individual nations
and international governing bodies, catastrophic
pandemics of the future will continue to cross
national boundaries and fly across oceans.
One of the best ways to develop a capable
emergency healthcare management plan for the
future is to learn from the past. Lessons from the
2014 Ebola outbreak certainly have a lot to teach.
Doctors without Borders sounded the alarm but
nobody listened, when, in April of 2014, the group
issued warnings that the Ebola outbreak was getting
out of control. This sparked a debate between the
charity organisation and a spokesperson for WHO,
who insisted they had the outbreak under control.
Dr Peter Piot, the co-discoverer of the Ebola virus
said that WHO acted too slowly, largely because of
its African office.
The CDC has continually fumbled its efforts to
prepare healthcare workers for a possible Ebola
outbreak. Reports of the outbreak had filtered into
US news for several months before the virus ever
hit American soil. This gave the CDC plenty of time
to prepare healthcare workers to identify Ebola and
safely treat patients with EVD, but the agency simply
did not seize the opportunity. Taking their cue from
the CDC, local hospitals did not adequately prepare
healthcare workers to recognise and deal with the
potential threat.
for an ambulance. By this time, the other individuals
in Duncan’s household had been in contact with
dozens of people, potentially spreading the deadly
disease to an untold number of people.
Doctors finally admitted Duncan on September
28 and diagnosed him with Ebola on September 30.
Several nurses and laboratory technicians worked
with Duncan directly and had contact with his body
fluids. During Duncan’s visits to the emergency
department and the first hours of admission to the
hospital, nurses and other caregivers did not employ
anything other than the standard infection control
protocol. Consequently, several healthcare workers
were exposed to the virus and a few came down
with the disease.
Meanwhile, officials quarantined Duncan’s
roommates in the apartment, along with the man’s
soiled sheets and clothing. Fortunately, the people in
the apartment sealed off Duncan’s belongings in a
bedroom and did not contract the virus. While the
quarantine worked to prevent the potential spread
of Ebola outside the apartment, sealing people in
small quarters with Ebola-infected material put the
citizens in harm’s way.
This scenario has occurred countless times in the
three countries most affected by the outbreak, with
a cycle of bad protocol and mistakes perpetuating
the spread of the virus. Patients often deny
exposure because they are afraid dying or, if they
live, worried that their community will ostracise
them. Healthcare workers miss important signs by
asking the wrong questions or ignoring evidence.
Hospitals and other healthcare institutions skimp
on training and equipment until the infectious
disease that is running rampant in other countries
actually strikes in their own neighbourhood, instead
of paying attention to the pandemics occurring on
foreign soil and creating a protocol to respond to
the threat ahead of time. Governing bodies impose
quarantines improperly, endangering lives rather
than protecting them.
The document also pointed out that the regional
heads of WHO in the affected areas were politically
motivated appointments. Dr Luis Sambo was the
WHO regional director for Africa; he did not
answer to the agency’s chief in Geneva, Dr Margaret
Chan. The hierarchy is the same for WHO’s other
regional directors, including those in the Americas,
Europe, Eastern Mediterranean, Southeast Asia
and the Western Pacific, where these directors are
elected by their regions and are not accountable
to the main office in Geneva. “Nearly everyone
involved in the outbreak response failed to see
some fairly plain writing on the wall”, WHO said in
the document. “A perfect storm was brewing, ready
to burst open in full force.”
There are some significant differences in the
two EVB outbreaks. The first occurred in remote
villages in Central Africa. The more recent outbreak
occurred in West Africa, primarily in urban areas but
cases appeared in rural areas as well.
EVB first appeared in 1976, erupting in two
simultaneous outbreaks. The first cases of EBV
occurred in Nzara, Sudan, and then spread to Maridi,
Tembura, and Juba. The second outbreak happened
in Yambuku, Democratic Republic of Congo, a small
village located near the Ebola River from which the
virus derived its name.
Numerous smaller outbreaks have flared up
throughout the years. While EVD inflicted an
unusually high mortality rate, healthcare workers
were able to contain, control and eventually quell
outbreaks. It seemed scientists could control Ebola
and confidence often gave way to complacency.
The current outbreak in West Africa is the
largest and most complex outbreak, with more
cases of the disease and deaths than all the other
outbreaks combined. The most recent outbreak is
also different because it spread between countries.
In an October 2014 draft document obtained by
Associated Press, WHO acknowledged its bungled
attempts to control the outbreak. Authors of the
document say that experts should have recognised
that traditional methods for containing infectious
diseases would not work in the outbreak regions
because of broken health systems and porous borders.
Healthcare providers can apply the lessons learned
from the Ebola crisis to develop a sound and robust
healthcare system that works as well globally as it
does locally.
To provide proficient healthcare management
to control future EVD outbreaks, we must apply
a package of interventions that includes cause
management, surveillance and contract tracing,
adequate laboratory services, and safe burials.
One of the most important components of
the intervention package is social mobilisation.
Community engagement, especially on the local
level, is essential to controlling outbreaks for many
reasons, including illiteracy and mistrust of outsiders.
Volunteers go to marketplaces, bus stations and
other busy places to disseminate information via
loudspeaker, answer questions, and sometimes
distribute soap and bottles of chlorine.
Future emergency healthcare management relies
on doctors and nurses who practice good medicine
with a strict adherence to protocol. This did not
always happen during the 2014 outbreak. Thomas
Eric Duncan presented a 39.4°C fever at Texas
Health Presbyterian Hospital on September 26 after
travelling to West Africa, according to nurse records.
The nurse also noted that Duncan denied exposure
to a sick person during his trip, which proved to be
untrue. The attending physician noted the patient
was ‘negative for fever and chills’ and discharged the
patient to home with antibiotics.
After spending several days in an apartment
with four other people, Duncan’s condition
worsened and concerned family members called
ARAB HEALTH daily dose
Newest launches on display for the first time in the Middle East
ince the establishment of its hub in the UAE
three years ago, Roche Diagnostics Middle
East has been providing continuous service,
support and expertise to the regional in vitro
diagnostics industry. Operating from this location,
allows Roche Diagnostics Middle East to fulfill its
commitment to healthcare professionals, bringing
them closer to the solutions and services that
meet their needs.This year, at the 40th Arab Health
Exhibition, healthcare professionals can have a
first-hand look at the latest innovations from
Roche Diagnostics and explore a complete stateof-the-art laboratory setup. At its stand this year,
the newest technologies in laboratory automation,
histopathology and coagulation are launched and
on display, such as the cobas® 8100, cobas t 411,
and the VENTANA HE 600.
For the first time in the Middle East, Roche
will display the cobas® 8100 automated workflow
series, a total lab automation solution that supports
Image © Roche Diagnostics
central laboratories. This cutting-edge solution,
like others from cobas®, is designed to help
healthcare professionals deliver smooth, efficient
in vitro diagnostics service, with comprehensive
technology including pre-analytics, analytics and
post-analytics. Whether a laboratory has high
throughput, short turnaround time or both, the
cobas® 8100 can fulfill the laboratory’s changing
needs, allowing faster and more efficient workflow.
The solution provides real value using its 3D
intelligent bi-directional transportation system with
STAT prioritisation, sample integrity and tracking,
and emergency sample handling. Furthermore, the
cobas® 8100 is designed with connectivity options
for a range of instruments, providing flexibility to
grow it as needed.
This year, Roche Diagnostics will also unveil its
entry into laboratory coagulation with the cobas
t 411. This coagulation analyzer begins a new era
for Roche in the world of coagulation, delivering
safety, efficiency and productivity. It is designed
to allow maximum flexibility for laboratories
with low to medium throughput. Best-in-class
reagent, sample and cuvette storage capacity
means the analyzer is not only easy to use but
also requires minimal interaction during daily
use. The cobas t 411 analyzer is designed with a
unique set of enhanced safety features to ensure
robust and high quality patient results, every time.
Other innovative features in the solution include:
automated, multi-vendor cap-piercing, maximised
reagent utilisation and integrated barcode
scanning for samples and reagents.
As Roche Diagnostics shares the vision of
healthcare professionals for exceptional patient
care and safety, the booth will also exhibit the
latest solutions for histopathology laboratories,
including the VENTANA HE 600 system. As
a leading player, Roche provided the first fully
automated H&E instrument ‘Symphony’, and
now the VENTANA HE 600 system, takes the
technology to the next step. With the VENTANA
HE 600 system, laboratories can rely on fully
automated, consistent high quality H&E staining
with no patient cross contamination in a simpler
and more cost-effective way.
The system provides from its ancestor
improved instrument reliability, higher throughput
of 200 slides/hour, no alcohol usage and reduced
reagent volumes for lower waste generation.
HE600 takes the next step towards full automation
in Hematoxylin and Eosin staining.
With innovations such as these, Roche
Diagnostics has maintained its position as a world
leader in in vitro diagnostics. With its high standard
technology and continuous innovation, Roche
Diagnostics’ solutions deliver quality and reliability
for more accurate results. Roche Diagnostics
Middle East is dedicated to equip healthcare
professionals with better diagnostic tools to
ultimately ensure better patient care. To witness
these advanced technologies and much more, visit
the Roche Diagnostics Middle East stand at Sheikh
Maktoum Hall, Stand MC 10.
icrobiology specialist Lab M will
showcase its new convenient culture
media product ranges at Arab Health.
With a commitment to providing high quality
products that aid laboratories in their efforts to
optimise efficiency and workflow, Lab M has long
been recognised for its comprehensive portfolio
of dehydrated culture media (DCM). Now
a number of these formulations are available
as Pinnacle™ pre-poured plates and µPREP™
ready-to-reconstitute bags for ease of use in any
laboratory. Lab M’s µPREP™ ‘just-add-water’ range of
culture media includes µPREP Half Fraser Broth
ISO (+FAC) for the isolation of Listeria spp and
µPREP Buffered Peptone Water (BPW) ISO
used extensively as a pre-enrichment medium
in Salmonella testing. These complete media are
provided sealed in a 20-litre bag. Simply adding
water through the filter means there is no mess
and no need to autoclave.
For ultimate convenience, Lab M now also
provides its microbiological culture media as
Pinnacle™ pre-poured plates. Users benefit from
plates, prepared by the manufacturer under a
stringent quality management system in a GMP
Managing Director of Lab M, Ian Morris said,
Image © Lab M
“We are very much looking forward to our second
attendance at Arab Health and building on the
successes of 2014. The last couple of years have
been important ones for Lab M having significantly
Booth no. S3D70
Sheikh Saeed Hall 3
grown our manufacturing facilities, head count and
R&D capacity. This has enabled us to commence
large-scale manufacture of pre-poured plates and
to launch a number of new products.”
Lab M specialists will be available throughout
Arab Health 2015 in Sheikh Rashid Hall, stand
RH33 to discuss individual requirements.
MONDAY 26 January 2015
“Everything we do,
we do with passion –
and we do it
for life.”
Stefan Dräger, Chairman of the Executive Board
3, B
t th
Visit us SHK. Saeed H
ARAB HEALTH daily dose
By: Dr Zeyad Al Moosa, Managing Director, GulfDrug
ulfDrug is proud to have such a long
association with Arab Health and
would like to congratulate everybody
involved with the event on its 40th anniversary.
Over the last four decades, Arab Health
has become one of the world’s largest medical
technology exhibitions and conferences. It
has catapulted UAE’s healthcare industry into
the focus of the entire world, and has brought
the world’s greatest medical technologies and
innovations together in one, big forum.
Our first participation in Arab Health dates
back to 1979. At that time it used to be a biyearly congress until it changed to a yearly event
in 2001. Since then, GulfDrug has benefitted
greatly from this event. Not only did it create
a sense of trust and commitment between all
parties to invest in the Middle East markets, but
also allowed the UAE to blossom into a regional
centre for manufacturers and providers to set up
their regional and international offices, as well as
support and training centres.
We have witnessed first-hand how Arab
Health has evolved from an exhibition where all
exhibitors could fit in two halls in the 90’s, to what
we see as a mega event today. It’s a clear reflection
of what a long journey we have covered and how
glorious our future is going to be.
All this history has contributed to what
Dr Zeyad Al Moosa
GulfDrug is today: A professional, knowledgeable
organisation, with provision of integrated
healthcare products and services, and capability
to completely fit out hospitals and clinics of all
sizes and complexities.
We at GulfDrug foresee that the growth
expectations for distributors and manufacturers
for the next five years will consistently be
in the double digits, due to the increase in
population, healthcare awareness, population
ageing, mandatory insurance coverage of the
population, an increase in healthcare tourism, and
increased investment in infrastructure in both the
governmental and private sectors.
We have already started implementing
major plans in increasing our investments in
infrastructure, facilities and people. Having moved
to our new head office in Al Barsha, Dubai in
November 2014, we have increased our ability to
absorb the increase in technical and operational
staff. In 2015 we are increasing our logistics
and warehousing capacity to better handle the
increasing volume of business.
We look forward to the years to come and
are happy to be associated with Arab Health,
which has and always will be a great exhibition
and conference that keeps building bigger and
more solid bridges between cultures, technologies
and people across the world.
Images © GulfDrug
There will be 118 French companies exhibiting their products at the Pavilion
organised by UBIFRANCE, the French Agency for International Business
Development. Occupying about 1,350m2 of exhibition space in the Za’abeel and
Sheikh Rashid HallS, the companies will be enjoying a much larger area to
showcase their know-how.
rance’s medical products and services
industry accounts for a market wor th
about €20bn, or 10% of the world
market. Driven by 1,079 high-added-value
companies in the field of medical technologies,
it is a cutting-edge industry enjoying constant
growth, employing 65,000 people. 94% of those
businesses have less than 250 employees. The
manufacturing techniques, which are highly
precise for a wide range of products, must meet
ethical and regulatory requirements in terms of
safety and quality. A large par t of production
operations (assembly, filing and polishing) are
done by hand; automated assembly is not always
possible, and some of the controls require a
human presence.
As a major event, Arab Health and Medlab
2015 attracts an increasing number of
manufacturers every year, hailing from all regions
in France and presenting highly innovative
products; 38% of them will be attending for the
first time. Found in both exhibitions, they will
display their latest products in or thopaedics,
diagnostics, healthcentre consumables and
facilities, air treatment, waste processing, hospital
supplies and home care.
With help from regional par tners like
CENTRECO and Lille Eurasanté, who will be
exhibiting at the French Pavilion with nine and
seven businesses respectively, the very latest
in French innovations will be clearly on display.
Their advanced technical skills are sure to meet
the requirements of a very demanding local
market which is currently experiencing a boom
in those fields.
Together with UBIFRANCE, Orange Business
Services is sponsoring the French Pavilion.
The Orange Group’s B2B division will be
introducing its own health-related solutions.
For the past 10 years, the Group’s entity
Orange Healthcare has provided its exper tise
in means of communication to serve healthcare
professionals. As the first telecom operator to be
cer tified as a ‘hosting company for private health
data’ by France’s Health Ministry, Orange has
played a par t in modernising infrastructures and
healthcare systems, as well as supplying health
centres with communication solutions. Orange
guarantees reduced costs, optimal quality and
improved access to health, for instance by
providing solutions to manage chronic illness.
MONDAY 26 January 2015
The TrueBeam® system – Radically different
TrueBeam created a revolution in Radiotherapy; it was the first
system that combined ultra-high dose rates with sub-millimeter
accuracy for ultrafast and safe treatment delivery.
It’s a versatile, innovative treatment platform for high-precision
The TrueBeam system enables a truly integrated approach
image-guided radiotherapy and radiosurgery.
to treating cancer with image-guided radiotherapy, allowing
clinicians to treat tumors located in close proximity to critical
More options for difficult cases mean more options for your
® for SRS. Simply
as a Technology.
as a Result.
Varian Medical Systems International AG
Cham, Switzerland
Phone +41 -41 - 749 88 44
[email protected]
ARAB HEALTH daily dose
View the exhibitor listing, product listing, interactive floor plans, and
all the show information you could need – all from your own device!
Download now:
Win a BMW 4 Series Gran Coupe: Visit stand Z4B60 in Za’abeel Hall 4.
Win a Dream Holiday worth AED 15,000 – DAILY! Enter each day at stand Z4AA60 in
Za’abeel Hall 4.
Win a Samsung Galaxy Tab 3: Take a selfie at the exhibition and upload it to social
media with #arabhealth
Visit stand Z4N60 in Za’abeel Hall 4 to benefit from a free networking lounge and free
coffee exclusively for Dealers & Distributors. Also visit the Dealers & Distributors Wall to
Cerner to showcase healthcare IT
solutions across the continuum of care
erner Middle East has joined thousands
of local, regional and global healthcare
companies at Arab Health 2015 to
demonstrate its broad range of healthcare
solutions and services. During the event, Cerner
will highlight IT solutions for the flourishing region’s
healthcare sector, including:
 A comprehensive behavioural health medical
record, including nursing workflows, specialised
patient summary pages, group and individual
therapy documentation, multi-disciplinary care
plans, electronic patient safety rounding, physician
speciality workflows and interdisciplinary patient
discharge workflows
 A fully integrated Women’s Health maternity
record to capture data spanning from the patient’s
first antenatal visit through delivery and the neonatal
record.The solution integrates unique elements of the
perinatal workflow with the patient’s medical record
 A HealtheLifeSM-enabled Population Health
patient portal to provide patients access to
clinical notes, upcoming appointments and other
information through a secure website. The patient
portal encourages individuals to become active
participants in their care by closely collaborating
with their care team.
“The emergence of universal healthcare
in the UAE is an opportunity to demonstrate
how Cerner’s technology-enabled solutions can
drive improvements and reduce costs for clinical
settings throughout the Middle East”, said Michael
Pomerance, Vice President and Managing Director,
Cerner Middle East and Africa. “Arab Health is an
ideal platform to discuss with industry leaders and
decision-makers ways to enhance the delivery of
healthcare services in the region.”
post your business requirements and contact details so exhibitors can get in touch with you
directly during the exhibition.
The Future of Surgery Zone at Arab Health is an interactive hub providing an opportunity
for healthcare professionals to learn about and experience innovative surgical methods and
technologies. The Future of Surgery Zone is located at the Plaza Hall.
Launched by Aster DM Healthcare in association with the Arab Health Congress & Exhibition,
this programme provides a platform for young healthcare professionals to showcase their
skills, improve their knowledge, and potentially become a permanent part of Aster DM
Healthcare. Visit stand Z4N30 in Za’abeel Hall 4.
Michael Pomerance
MONDAY 26 January 2015
ARAB HEALTH daily dose
MONDAY 26 January 2015
he certified CARESTREAM Vue PACS,
which has passed strict DIACAP security
tests, is showcased on the Carestream
stand during Arab Health.
As a result of meeting some of the most stringent
product security requirements for the US Navy’s
DIACAP certification process, Carestream is now
the first company approved to provide the latest
Picture Archiving and Communications Systems
(PACS) for use in US Navy medical facilities.
Carestream has received an official ATO
(Authorization to Operate) from the Department
of Defense (DoD) Information Assurance
Certification and Accreditation Process (DIACAP),
enabling the Navy to implement Carestream’s
Vue PACS at any Naval medical treatment facility
across the globe. DIACAP is a process by which
information systems are tested and certified for
compliance with DoD security requirements and
accredited for operation.
While security testing of new systems typically
occurs in a lab environment, Carestream’s PACS,
along with its cardiology PACS feature, was
successfully tested in an extremely complex
environment at one of the largest DoD hospitals
that performs more than 300,000 radiology exams
a year. Carestream’s native reporting application—a
voice recognition and reporting feature that allows
remote reading by radiologists, which expedites the
delivery of radiology reports and helped eliminate
transcription costs—was also included in the Navy’s
field testing process.
With the diagnostic viewing capabilities of
Carestream’s Vue PACS, users can consolidate
the reading of all medical imaging exams onto a
single platform, which can boost productivity while
simplifying operations and support. Its scalable,
web-enabled platform integrates smoothly with
complex environments and complies with XDS,
HL7, DICOM and IHE standards.
Carestream Vue PACS offers radiology reading
tools such as MPR, MIP, MinIP, volume rendering,
tissue definition, vessel tracking, and cardiac analysis.
The PACS can automatically register 3D imaging
data sets (such as MR and CT) to help highlight
subtle changes in anatomy and improve clinical
collaboration. Vue PACS also provides lesion
management as a native clinical tool that can simplify
the comparison process between different data sets
and supports oncology follow-up with bookmarking
and tracking of general anatomy over time.
As part of Carestream’s ‘Knowing Matters’
customer strategy, Carestream’s Vue portfolio of
healthcare IT solutions is designed to offer greater
value and insight for clinicians, foster collaboration,
control costs, and streamline dataflow. The
company’s Vue solutions amplify the clinical, business
and IT value of radiology services.
Carestream’s x-ray products and healthcare IT
systems are used by the US government’s veterans
integrated service networks, the US Army and US
Air Force, as well as by many foreign governments
around the world.
The company regularly receives high marks for
the performance of its Vue PACS for use in radiology,
cardiology and mammography, with some of the
most well-known hospitals and national healthcare
systems implementing Carestream’s PACS.
Carestream’s Vue PACS. Image © Carestream
demo For a
visit nstratio
S3D70 s at stann,
in Sh
She Savors Every Moment
With Her Grandchild
Thanks To
Early Detection
Advanced Medical Imaging at American Hospital Dubai
The hospital’s advanced medical imaging technology including a range of digital body scanners
that detects serious disease quickly. From cancer to neurological conditions, these scanners
present detailed images in real time, enabling fast diagnosis with a high degree of patient
Tests are designed to show even the smallest changes in your body, from cancer development
to treatment response and any recurrence.
This new technology makes it possible to diagnose and treat disease earlier, allowing patients
to live a better and healthier life.
Tel +971 4 377 6015/6669
Email [email protected]
ARAB HEALTH daily dose
orkflow management is one of the
greatest operational challenges
facing hospitals today. Patients
wait in the A&E while someone calls to see if a
bed is available on the patient ward. OR costs
skyrocket due to downtime from cancelled
procedures. Hospitals have been lacking the
insight into workflow and patient throughput
that delivers measurable economic benefits.
MAQUET recognises the value of a
comprehensive, easy-to-use clinical logistics
system that gives clinical staff the information
that they need to improve patient care.
INSIGHT Clinical Logistics features four
components, each specifically geared to the
clinical area that it ser ves; emergency, surgical,
ICU and patient ward.
Foundation funded an independent study
of the emergency component. It showed an
increase in productivity as patient throughput
was increased by 19% after INSIGHT was
implemented at the regional hospital of
Horsens, Denmark.
The system tracks patients from admission
to discharge, often star ting in the accident and
emergency depar tment. “INSIGHT Emergency
has had an incredible effect on our over view”,
says Ove Gaardboe, Chief Physician. “We are
saving time and improving the quality of our
INSIGHT Clinical Logistics is designed to
improve interdepar tmental communication.
Because the OR status is being tracked at all
times, all surgical suite staff know the status
of each procedure. Cleaning crews can be
queued and ready for an efficient turnaround,
while patients are prepped and ready.
“INSIGHT Surgical has improved our
working environment drastically”, says MarieLouise Ulsøe, Head Nurse. “The work has
become less stressful and we have increased
the number of operated patients per day.”
An assessment of the surgical component
has demonstrated positive outcomes with a
15% higher utilisation of operating rooms and
a 66% reduction in the number of cancelled
Large touchscreens present each area of
the hospital with exactly the information that
they need. There is no hunting for critical data
and unnecessar y information to waste time
sifting through. “We have a significantly better
over view over the treatments and flow of our
patients as well as our staff ”, explains Ulsøe.
INSIGHT Clinical Logistics is designed to
be easy for ever yone to use, with a minimal
learning cur ve. “It was surprisingly easy for
the staff to implement the solution and learn
how to use it”, explains Claus Brøckner, Chief
Surgeon. “Ever yone, even those who normally
are sceptical about star ting to use new IT
solutions, has been happy with the new system
because it’s so intuitive.”
The Clinical Logistics Solution
• Efficient workflows throughout the hospital
• Easy access to all relevant information
• Improved interdepartmental communication
• Four components: Emergency, Surgical, ICU and PatientWard
Maquet | The Gold Standard
Visit us in Sheikh Saeed Hall 2, booth no. S2G30 and see how INSIGHT can streamline clinical workflows
MONDAY 26 January 2015
ARAB HEALTH daily dose
or almost 70 years, KARL STORZ have
been globally known to physicians as a
manufacturer that provides the various
medical specialities with a full range of high quality
products. KARL STORZ’ customers receive all their
requirements from a single source with products
that range from endoscopic instruments to hightech documentation solutions, fully integrated
operating rooms, and software-supported
workflow solutions.
At this year’s Arab Health, KARL STORZ
will showcase intelligent novelties in endoscopic
imaging and data management, as well as the
innovative solutions for clinical communication and
optimization of workflows.
flexible integration of the new technology into the
existing camera platform IMAGE1 SPIES™.
For imaging beyond the white light mode,
KARL STORZ offers the ICG fluorescence-supported
NIR (near infrared) system, a cost-effective option for
perfusion assessment, lymph node detection, and bile
duct visualisation during surgical procedures.
Within the same context, we will be unveiling the
newest generation of the KARL STORZ AIDA®
KARL STORZ technical solutions for targeted
enhancement of endoscopic imaging information
allow physicians more precise assessment of
the surgical site. The IMAGE1 SPIES™ FULL HD
platform offers the endoscopic standard image with
three additional visualisation technologies: Contrast
enhancement, homogeneous image illumination,
and spectral hue shifts. Tissue will thus be visualised
in a more differentiated manner specific to the
individual diagnosis and surgical situation.
The latest 3D camera generation, which is a
new and essential component of the company’s
system approach, has now expanded the modular
endoscopic camera platform IMAGE1 SPIES™ by
incorporating a 3D module in FULL HD quality,
with obvious advantages to the user, such as but not
limited to, a more brilliant image quality in 3D and
documentation unit, which now has the option of
recording and displaying 3D image information.
Following data generation, structured data storage
and utilisation has to be ensured; KARL STORZ
addresses this demand with the latest version of
the AIDA Advanced Reporter (AAR). The AAR
is a solution that supports physicians who wish
to generate reports in both a structured and
individualised manner.
With the innovative communication system
VISITOR1®, KARL STORZ offers an intra-operative
telementoring robot, which allows virtual integration
of external experts during surgical procedures and
provides solutions for clinical communication and
workflow/resource control.
With more than 3,000 installed OR1™ systems,
KARL STORZ is the leader in the field of integrated
operating rooms. The OR1™ allows centralised
and ergonomic control of endoscopic devices via
touchscreen or speech control from within the sterile
area and simultaneously offers an archiving system
with numerous functionalities. Furthermore, the OR1™
facilitates worldwide telemedical communication from
the OR via audio and video transmissions.
The new generation KARL STORZ OR1
FUSION™ is based on IP network technology and
enables the digital transmission of video and audio data
with virtually no delay and no compression. Additional
sources can be integrated through the dynamic Plug
& Play solution to ensure flexibility. Furthermore, the
new generation only requires universal network cables,
which further facilitates integration of the devices.
With the IP network technology, KARL STORZ OR1
FUSION™ is perfectly ready for future developments
in medical technology.
With these exhibition highlights, KARL STORZ
once again reinforces its reputation as an innovative
leader, that impressively substantiates the ranking
of the German business weekly WirtschaftsWoche,
which in April 2014 named KARL STORZ as the
‘most innovative German medium-sized company’.
With more than 50 domestic and global
subsidiaries, KARL STORZ once again presents itself
as a globally active family company that consistently
invests in research and development and in
customer service and support.
MONDAY 26 January 2015
Article provided by Siemens Healthcare
ith the new version of the
Siemens Healthcare has created the
basis for establishing the dual energy procedure
in clinical routine. The innovative x-ray tube
concept in the new CT scanner, enables
simultaneous imaging at two different energy
levels for the first time in single source computed
tomography. Thanks to a novel user- and patientfriendly measurement method, information on
tissue and other material can be obtained as well
as traditional morphological data, even during
examinations with high contrast media dynamics.
This means that more patients will benefit from
the added value of dual energy imaging.
detector side after penetrating the patient. With
kV-switching, the segmentation of the measuring
points significantly impairs the image quality due
to the limited data per energy level. At the same
time, increased x-ray doses are inevitable because
the dose cannot be modulated to reduce radiation.
Not so with the TwinBeam Dual Energy technology
from healthcare, in which the x-ray beam emitted
is split into two different energy spectra before
reaching the patient thanks to an innovative tube
design. This means that the SOMATOM Definition
Edge generates the dual energy images at the same
The benefits of the new procedure are
illustrated by the diagnostics in a case of suspected
pulmonary embolism: Due to the improved tissue
differentiation and the precise representation of
contrast media distribution, vascular occlusions can
be quickly identified and their size determined.
In addition to increasing the diagnostic strength
of clinical images, TwinBeam technology also
minimises the x-ray dose required in a different way
to other single source dual energy procedures. All
dose-reducing Siemens technologies can be used
with the SOMATOM Definition Edge. This now
In dual energy imaging, the same region of the
body is examined using two different energy levels.
The two datasets offer more detailed information
about tissue composition that goes beyond pure
morphology. For instance, metal artifacts caused
by implants such as artificial hips are reduced
considerably, while tissue and bone structures can
be displayed more clearly. However, in cases where
data have been acquired using fast kV-switching or
dual layer detector technology – dual energy imaging
involved significant drawbacks. Single source dual
energy images acquired with these methods were
excluded for many important radiological use cases,
because the tube does not emit the two energy
spectra at the same time, only in succession through
rapid switching or through spectra separation at the
With the new version of the SOMATOM Definition Edge, Siemens Healthcare has created the basis for establishing the
dual energy procedure in clinical routine. The innovative x-ray tube concept in the new CT scanner enables simultaneous
imaging at two different energy levels for the first time in single source computed tomography. Image © Siemens Healthcare
also includes ADMIRE, the model-based iterative
reconstruction procedure that was just recent
released on the SOMATOM Force and whose
scanner-specific algorithms can reduce x-ray doses
further still, achieving excellent image resolution and
extremely low image noise even at low doses.
To further improve not only the quality of dual
energy examinations, but also of conventional CT
scans, Siemens Healthcare is additionally introducing
a new iterative algorithm for metal artifact
reduction with the new SOMATOM Definition
Edge: iMAR.This allows respective artifacts – caused
by implants, artificial joints or pacemakers – to be
reduced significantly. Such artifacts may lead in the
worst case to non-diagnostic images by concealing
the relevant pathologies.
Even if a radiologist wishes to check whether
bone fractures have healed and metal objects
such as screws and plates can be removed, the
iMAR algorithm can be used to clearly assess the
anatomical details in the area of transition between
bone and metal. With the aid of iMAR, streak
artifacts can, for instance, be significantly reduced
in clinical images, according to first scientific results.
The products/features (here mentioned) are
not commercially available in all countries. Due to
regulatory reasons their future availability cannot be
guaranteed. Further details are available from the
local Siemens organisations.
Visit us at
booth S1D10,
Sheikh Saeed
Hall 1
Improve patient outcomes while reducing annual operating costs by up to 20.000€1
Providers and stakeholders around the world are working to increase the efficiency of
healthcare systems. The aim: to achieve better outcomes for patients.
With MAGNETOM Amira you can:
MAGNETOM Amira2 is specifically designed to enhance clinical capabilities and deliver
comprehensive, advanced MRI technology. It helps extend care to a greater number of
patients, improve the patient experience and boost process efficiency – at lower costs per scan.
• Gain diagnostic value with FREEZEit
• Increase patient comfort with Quiet Suite
• Streamline operations with 10-min exams
• Save 30% energy3 with Eco-Power
Comparison with older MRI generations.
Data on file.
MAGNETOM Amira is currently under
development; is not for sale in the U.S. and
other countries.
Its future availability cannot be guaranteed.
During standby mode. Data on file; results
may vary.
Answers for life.
2661_MR_Ad_Magnetom_Amira_en_267x180_K1.indd 1
16.12.14 08:17
ARAB HEALTH daily dose
Philips is introducing a fresh perspective on the future of health at Arab Health 2015
oyal Philips is a diversified technology
company, focused on improving people’s
lives through meaningful innovation. Philips
looks beyond technology to the experience of
patients, providers and caregivers across the
patient journey. This year at Arab Health, Philips
is showcasing some of its latest innovations
spanning across healthy living, prevention, diagnosis,
treatment, recovery and home care, telling a rich
story that demonstrates meaningful innovations
across the health continuum.
Philips is committed to delivering solutions for
the most meaningful moments of care, whether
in the hospital or at home. Dedicated to helping
people maintain their health outside the doctor’s
office, Philips helps clinicians make better informed
decisions for their patients, bringing together clinical
breadth and depth of expertise, technology and
services, actionable data, consultative new business
models and partnerships.
Improving experiences of patients, providers and
caregivers means moving outside the hospital walls.
In today’s healthcare environment, it’s not enough to
just diagnose and treat. Patients and clinicians alike
are looking for ways to manage health conditions
before issues arise, and to stay healthy long after
treatment. Philips solutions are strategically
developed to work cohesively across the patient
The key focus at Arab Health revolves around
the latest innovations across prevention, diagnosis,
treatment and recovery.
Philips provides digital solutions to measure
and monitor the patient’s condition, and empower
patients to take control of their own health, such
as the HealthSuite Digital Platform that seamlessly
integrates data to transform the delivery of patient
care and provide better access to data from hospital
to home.
To drive definitive diagnosis, Philips offers
solutions that are designed for ‘First Time Right’
imaging, helping providers manage workflow
efficiency. Some of the key innovations showcased
at Arab Health for the first time include the Ingenia
1.5T S complemented with the patient in-bore
solution to create an immersive experience, allowing
the patient to relax through the exam, the Affiniti,
ultrasound system, providing innovative technology
to help radiology/ultrasound departments facing
more patients with fewer resources deliver high
quality patient care, and IntelliSpace Portal 7.0,
combining high quality images, advanced analysis,
and workflow efficiency tool into a single advanced
analysis solution.
In the area of treatment, the Veradius Unity
makes its debut at Arab Health. Designed to
improve the workflow and throughput by
establishing exceptional communication between
the physician, operator and C-arm, the Veradius
Unity is an example of how Philips creates new
clinical procedures for safe and effective adaptive
Philips’ breadth of diagnostic and treatment
solutions offer real-time tools to connect patient
information with clinician knowledge, resulting
in more personalised care, while innovations for
recovery and wellness provide a safer transition
from hospital to home.
improve the lives of 3 billion people by 2025. Ageing
societies and the rise of chronic diseases means
healthcare costs are spiralling out of control. People
are beginning to value their health and wellbeing
more, as technology becomes more pervasive,
integrated and intelligent and at home, it changes
how people behave.
To make healthcare more effective there is a
need for more integration and personalisation.
Patients will benefit from faster and better diagnosis,
efficient personalised treatment and better
aftercare. In short: healthcare that is more accessible,
with better outcomes at lower costs.
Philips is uniquely positioned to help reshape
and optimise population health management by
leveraging big data and delivering care across the
health continuum, from healthy living and prevention
to diagnosis, minimally invasive treatment, recovery
and home care. Philips believes that opportunity lies
in an increasingly connected world, where societies
are looking for more effective and lower cost health
solutions, meaningful innovations built around people.
See it yourself during Arab Health at Philips stand
S2C10, or visit
Following its rebranding and new positioning
‘innovation and you’, Philips has continued to
demonstrate its commitment to addressing the
needs of the people and of the world as a whole, to
Image © Philips
meets wow
Choosing a new ultrasound system is all about balance. You want
the latest technology that needs to be out of the box usable.
You need accurate diagnostic information quickly, a simplified
yet intuitive user interface, and easy access to the critical
features to produce the results you need. All in an ergonomic
design, to let you work with less reach and fewer steps.
You want the new Philips Affiniti.
Visit us at booth # S2C10
The new Philips Affiniti ultrasound system.
It understands your everyday.
Philips_Affiniti_PrintAD_267x180_v1.indd 1
09/12/14 13:45
MONDAY 26 January 2015
Shanghai in China is home to the world’s largest
network of metro stations in the world. The trains
made 2.5 billion trips last year alone, covering 334
total miles of track and serving more than 8 million
people every day.
It’s impressive, but nothing compared to the
volume, distance and speed of blood moving
through the human body. The average adult body
has 5.5 litres of blood, which circulates through the
entire body three times every minute. Laid end
to end, the total length of all the body’s arteries,
capillaries and veins can reach up to 96,000km,
enough to wrap around the earth twice.
Like metros, the vascular system is made up
of different parts, each playing a specific role in
transporting oxygen throughout the body. Arteries
carry high-pressure, fast-moving oxygenated blood
from the heart to the rest of the body. They feed
into capillaries, which slow the flow of blood enough
for surrounding tissue to absorb oxygen, decreasing
the blood’s pressure at the same time. When it has
no more oxygen to deliver, blood (by then lowpressure and slow moving) moves into the venous
system, which carries it back to the lungs and heart
to be re-oxygenated.
Like any metro system, the vascular system can
fall victim to crippling congestion. Heavy traffic in
areas only capable of supporting low traffic can
cause delays and breakdowns. That’s what happens
when the body develops an Arteriovenous
Yousef Alrkhayes and his father. Image provided by Boston Children’s Hospital
hen Yousef Alrkhayes was diagnosed
with a rare, life-threatening Vein of
Galen Malformation (VOGM) at just
a few days old, his parents wanted the world’s
best care for their son. That meant travelling from
Kuwait to Boston Children’s Hospital with Yousef.
Malformation (AVM). The body never develops
capillaries in specific areas, leaving high-pressure,
fast-moving blood to flow directly into the veins.
Without the capillaries, the blood doesn’t slow
down enough to deposit oxygen to the surrounding
tissue, which then signals to the heart that it needs
more oxygen. The heart starts pumping harder and
harder and harder, creating a vicious cycle.
“The hearts of children with AVMs are beating
very rapidly, all the time,” Darren Orbach, MD,
PhD, interventional radiologist at Boston Children’s
Hospital explains. “It’s not even just the speed, but
also the contractility; the heart increases its oomph
with each squeeze.” This supply and demand
problem was the very cause of Yousef ’s heart strain,
but at the time, back in Kuwait, no one knew the
problem was rooted in his brain.
Darren Orbach, MD, PhD, interventional radiologist
at Boston Children’s, treats as many as 15 VOGM
patients every year. That track record went far in
reducingYousef’s family’s fears. Most surgeries to correct
VOGMs involve inserting a catheter into a major artery,
usually entering mid-thigh, and then snaking it around the
heart and neck to reach the brain.The surgeon inflates a
small balloon attached to the outside of the catheter to
close off the connection between the arteries and veins
and then injects a glue to seal off the connection. Once
the glue has set, the balloon is deflated and the surgeon
removes the catheter.Yousef’s surgery stretched out to
seven hours. However, Dr Orbach successfully treated
the malformation, puttingYousef on the path to an active
and full life.
To read more about Yousef and Boston
Children’s #1 ranking in Neurology and
Neurosurgery by U.S News & World Report, visit
Modular Interior Construction...
Is it a better Approach for healthcare?
One of the things we trying to change is our behaviors as it relates to how we build out our interior environments in Healthcare
applications. The amount of change that occurs with-in hospitals is constant: most hospitals have a permanent construction trailer
on site to be able to handle the reality of their environments not being able to keep up with the need for flexibility.
“There is a better way to design and build our interiors”, one that gets away from fixed in place construction.
None of us has a crystal ball; we don’t know what technology is going to look like 2 years,
4 years, or 10 years from now. Yet we are trying to design spaces conventionally that
are in need to be flexible enough to handle whatever may be coming our way.
Construction behaviors in healthcare environments need to change,
focusing on reduce and reuse, saving costs through rapid interior
construction and enhanced coordination, creating environments that help
the overall healing process of patients and retention of staff.
This is true sustainability - and this is what NMG modular interior solutions are all about.
Image © NMG solutions
NMG (Inspired Design-Build Solutions). We look forward to welcome you at Arab Health 2015, Hall 4 Booth 4B50
ARAB HEALTH daily dose
Cielo Healthcare is the leading provider of
Recruitment Process Outsourcing (RPO), Strategic
Recruitment Projects and Physician Hiring Solutions
to Healthcare organisations across The Middle East
and North Africa (MENA).
Our teams based in Dubai, Qatar, KSA and other key
MENA locations interface with Cielo Healthcare’s
world-wide network of offices to find, attract,
engage and hire critical local and global talent
for our dedicated Healthcare clients.
Moorland Gray, previously Carmichael Fisher
Middle East, is the largest and most successful
executive search firm in the MEA region having
delivered more than 1,000 searches in the past
eight years.
Moorland Gray has improved performance for
hundreds of healthcare clients across the region
and are the first port of call for Chairmen
and Chief Executives looking to strengthen
their leadership teams. | +971 (0) 4 279 6300
Eradicate recruitment agency usage, access the very
best global Healthcare professionals and save your
organisation money with an in-house Recruitment
Solution from Cielo Healthcare MENA.
www.cielotalent/HC | +971 (0) 4 279 6302
Recruitment Process Outsourcing | Physician Recruitment | Consulting
he THUNDERBEAT Open Extended Jaw
was launched to the Middle East markets
in December 2014 and will be showcased
at Arab Health for the first time. It is the first
Olympus product to be specially designed for use
in open surgical procedures.
THUNDERBEAT Open Extended Jaw is based
on the established THUNDERBEAT concept of
synergistic energies. With one crucial difference:
The instrument has been further optimised to suit
the requirements of open surgery. Compared to
the laparoscopy model, it is shorter overall, but its
jaws are 25% longer to enable comfortable use.
THUNDERBEAT Open Extended Jaw cuts quickly,
reliably seals blood vessels, and enables very
precise tissue dissection, without any unwanted
bleeding. The ergonomics of the handle have also
been adjusted to facilitate accurate operations.
“THUNDERBEAT Open Extended Jaw is one
of the most versatile instruments currently on
the market”, says Frank Drewalowski, Managing
Director, Medical Systems Division, Olympus
Europa SE & CO. KG. “Our aim was to offer
surgeons the THUNDERBEAT precision and
convenience they are already familiar with in
laparoscopies for open procedures.”
In addition to general surgery, the
THUNDERBEAT Open Extended Jaw is particularly
THUNDERBEAT Open Extended Jaw; Energy Devices Olympus Europa.
Image © Olympus Europa SE & Co. KG
suitable for gynaecological and urological
procedures. As with the THUNDERBEAT model
for laparoscopies, the THUNDERBEAT Open
Extended Jaw can also be used in the integrated
Olympus ENDOALPHA operating room.
The laparoscopic THUNDERBEAT was launched
on the market in 2012. In its development,
Olympus was focused on a very clear goal: The
instrument needed to be as versatile as possible
in order to reduce the number of instrument
changes, decrease operation time, and limit blood
loss, thereby enabling procedures to be performed
in a more precise and gentle manner. This also
meant added safety for patients and surgeons.
THUNDERBEAT is the world’s first instrument
to combine a bipolar high-frequency current with
ultrasound technology to create a synergistic form
of energy, which reliably cuts and seals tissue and
vessels in one step, thereby enabling fast, precise
and safe surgical procedures.
THUNDERBEAT is currently the fastest cutting
instrument of its kind. It allows surgeons to reliably seal
blood vessels up to and including 7mm in diameter,
with minimal thermal spread. The instrument is
extremely versatile, as it provides surgeons with
a dissector, cutting instrument (ultrasound) and
sealing instrument (bipolar) in one product. The
THUNDERBEAT system consists of two generators.
In addition to its ultrasound generator, it also
features a complete, integrated high-frequency (HF)
generator compatible with most conventional HF
instruments found in operating theatres, rendering
the use of different HF systems superfluous.
ee t
To s
THU Exte the
n isit nd
O w, v
Ja pus s ing
Oly 30 duralth
3E b He
Ara 2015
 With an elongated tip, fine design and jaw
opening force, it allows surgeons to perform the
most intricate tissue dissection tasks
 THUNDERBEAT can reliably seal even large
vessels with diameters of up to and including
7mm, meaning they do not need to be clamped
or ligated
 Secondary bleeding can be immediately stopped
by the bipolar mode
 With its atraumatic teeth and uniform tissue
compression, the jaw design allows the tissue to
be gripped and held safely
 The ergonomic handle and its optimised angle
adjustment reduce surgeon’s hand fatigue.
MONDAY 26 January 2015
Advancing the art of Endoscopy
In the pursuit of the perfect endoscopy system, Olympus introduces EVIS LUCERA ELITE as the next milestone towards improved clinical outcomes
Visit us on stand 3E30 at Arab Health 2015.
Follow us on Twitter @OlympusMedUIMEA
ARAB HEALTH daily dose
Article provided by Aster DM Healthcare
Dr Azad Moopen
uality professionals are the need of the hour
for the healthcare sector in UAE and India.
Aster DM Healthcare has been a trusted
name for nearly three decades with 239 establishments
of compassionate care across eight countries, served by
more than 10,000 employees, 1,100 doctors, offering
more than 4,000 hospital beds.
The Aster DM Apprentice programme is presented
in association with the 40th edition of Arab Health
Congress & Exhibition. The four-day long programme,
the first of its kind in the GCC, intends to provide a
platform to young healthcare professionals to showcase
their skill sets, upgrade their knowledge and be a part of
the healthcare group.
Commenting on the launch of Aster DM
Apprentice at Arab Health, Dr Azad Moopen,
Chairman and Managing Director of Aster DM
Healthcare, said, “We are excited to be one of the
key associates of Arab Health Congress, the region’s
most important scientific medical demonstration.This
is part of our commitment to support innovation
and development of the region’s healthcare industry.
We will host Aster DM Apprentice in the next three
years consecutively, continuing through the 2016-
and 2017 editions of the Arab Health Congress.”
The programme is open for candidates with
MBA/MHA (Masters in Healthcare Administration)
and 2-3 years clinical or healthcare experience,
or any postgraduate with 5-6 years of hospital/
clinical experience. Aspirants should submit their
CVs to [email protected] Aster DM’s
healthcare panel will look over the CVs and shortlist
candidates and finalists by assigning a specific set of
subject-related tasks.
“The Aster DM Apprentice programme will
present competency-based models to healthcare
professionals participating in the Arab Health
Congress, in response to the need of the region’s
healthcare sector for highly skilled healthcare
workforce”, Dr Moopen explains.
Participating in the event will open up avenues
for acquiring, updating and fine-tuning knowledge
and skill sets in the healthcare sector. The winning
candidate will be with working with us for at least
a year. The candidates selected as apprentices will
work along with the C Suite of Aster DM Healthcare
including the Chairman for six months with successful
apprentices absorbed as full-time staff.
BMW 4 Series Gran
Sponsored by
Drop your Coupon at Stand Z4B60
Win a Holiday worth
AED 15,000 Daily!
Drop your Coupon at Stand Z4AA60
niversity Hospital Sharjah (UHS) is
participating in the prestigious Arab
Health Exhibition & Congress for the first
time in 2015. Speaking about the event, Mr Michael
Stroud, CEO of UHS, remarked, “Arab Health is
one of the most important global events in the
healthcare calendar and we will be making use of
this opportunity for us to meet and network with
fellow professionals from the healthcare industry
to share experience and expertise. The exhibition
also represents one of the largest gatherings of
healthcare innovators, suppliers, and distributors
and we will be leveraging this chance to get a
finger on the pulse of the latest developments in
the sector to explore new technologies that can
expand and further improve the medical services
we are proud to offer the people of Sharjah and
the UAE.”
The UHS CEO went on the comment that in
light of the hospital’s rapid growth, UHS was also
Michael Stroud
Win a Samsung Tab
with the Sele Competion
Take a sele at Arab Health and
upload it on our social network for
your chance to WIN a Samsung
Galaxy Tab 3
All at the new
Za’abeel Hall 4
constantly on the lookout to expand its talent pool
and that Arab Health offers a unique opportunity
to make direct contact with respected and highly
experienced healthcare professionals. “As a leading
healthcare provider, we place extremely high value
on recruiting and retaining the best medical staff
in the region and this is a wonderful chance for us
to meet with talented professionals who can add
value to our offering”, Stroud added.
UHS’ participation in the 2015 edition of Arab
Health will mark its debut at the prestigious event
and the has taken a 24m2 stand on the concourse,
in close proximity to the stand of the Dubai Health
Authority, showcasing the hospital’s advanced
medical offering, including its groundbreaking
programmes such as the Sharjah Breast Centre
being run in collaboration with Gustave-Roussy,
which is one of the worlds’ leading cancer research
institutes and the biggest health centre dedicated
to oncology in Europe
MONDAY 26 January 2015
get social
Get social with us on twitter and facebook using #arabhealth and be in
with a chance of featuring on this page tomorrow! Happy tweeting!
Kat Trinder @ kattrinder PR
I’ll be flying out to Dubai this time next week for @Arab_
Health. Looking forward to putting names to faces on the UK
pavilion. #arabhealth
Spok EMEA @spok_EMEA
Barry Clarke @
Great to see new jobs from locally grown innovators in
Northern Ireland. Look forward to seeing #Randox at
#ArabHealth @InvestNI_MEast
We are looking forward to attending #arabhealth 26-29
January in #Dubai! Plan to visit Spok in hall 1 at stand 1F53
Alfanar @alfanarVIP
If you want to go fast, go alone. If you want to go far, go
together - African Proverb @heshamoda #Egypt #arabhealth
Networkexecutive @CNetexc
Looking forward to attending the @Arab_Health 2015
Conference #arabhealth #Dubai #conference
Hamilton Medical @
We are looking forward to meeting you at this year’s Arab
Health in Dubai (Booth #S2F50, Saeed Hall). #arabhealth
Hiral Chavda @AscomHiralC
The first exhibition i’ll be attending in my new role. If you’re
visiting #ArabHealth please visit our stand. #newjob
Attune Technologies @attunetech
Martel Instruments @martel_inst
Making the trip to @Arab_Health this January? Our sales manager @
mattpw2013 will be there. Let us know if you will be too. #Arabhealth
Tobias Gilk @tobiasgilk
Who will be attending #ArabHealth in a few weeks? Please let
me know and/or stop by the [email protected] booth PZ
C51, and say “Hi”.
Can’t wait to meet all the exhibitors, sponsors, delegates and participants at
#arabhealth ! 2 weeks to go
Fahim Qaiser @drfahim
Looking forward to see new technologies and companies at
#arabhealth 2015 in Dubai.
Visit us
at booths
S1D10 and
Siemens welcomes you
to Arab Health 2015
The Middle East is a diverse and rapidly developing region,
experiencing a period of sustained economic growth that has
resulted in an increasing focus on healthcare investment. Siemens
has been a reliable partner to the region for over 150 years and
during this time, Siemens has supplied numerous medical imaging
and laboratory diagnostics equipment and expertise to many
important healthcare projects.
This year’s Arab Health exhibition presents a great opportunity for
the healthcare industry to convene, share ideas and to exhibit latest
innovations. Siemens certainly has much to present at the show,
with its wide range of medical imaging and laboratory diagnostics
equipment. Visit the Siemens booths at Arab Health this year to
learn more.
“As a company, Siemens has a record of
consistent innovations which is a result of
the strong focus we have in R&D, since we
understand the demands and necessities
faced by healthcare providers today. Our aim
is to develop products that can help combat
the most pressing health issues of today;
to design solutions that enable more informed
diagnosis; to make Healthcare more efficient
and affordable; and to make the investments
of today pay off in the future.”
Kay Zwingenberger, Head of Healthcare for the MEA region
Answers for life.
Please tear off along the perforation.
This year’s highlights …
… at the Siemens booth S1D10 in Sheikh Saeed Hall 1
Cios Alpha – See the power with Full View FD
The first mobile C-arm to use Full View FD technology and
the Retina Imaging Chain with IDEAL (Intelligent Dose
Efficiency Algorithm) dose reduction: Cios Alpha1 covers the
needs of all relevant clinical disciplines, opening up new
possibilities in surgical imaging.
Women’s Health
Mammomat Inspiration PRIME Edition
The reference in low-dose mammography.
Siemens proudly presents the Mammomat Inspiration
PRIME Edition1. Unique PRIME Technology starts a
revolution in mammography. It allows for up to 30% less
dose and uncompromised image quality2. The new, faster
direct-to-digital aSe detector and dose saving algorithms
individually calculate the exposure. Get a all-in-one system including
Stereotactic Biopsy3 and True 3D Breast Tomosynthesis1,3 which features
the industry’s widest angle of 50° for enhanced diagnostic capabilities
and new HD Volume Reconstruction for high definition image quality.
Cios Alpha is not commercially available in all countries. Due to regulatory reasons its future availability
cannot be guaranteed. Please contact your local Siemens organization for further details.
Mobile X-Ray
Mobilett Mira Max – Your mobile imaging companion
Mobilett Mira Max1 is your mobile imaging
companion that lets you bring a broad range of
unique MAX advantages to the entire hospital –
in a compact, powerful X-ray system that’s
always ready to go.
The products mentioned are not available in all countries. Due to regulatory reasons their future
availability cannot be guaranteed. Please contact your local Siemens organization for further
Compared to grid-based acquisition with Mammomat Inspiration, depending on breast thickness.
Mobilett Mira Max is not commercially available in all countries. Due to regulatory reasons its future
availability cannot be guaranteed. Please contact your local Siemens organization for further details.
Refurbished Systems
One, two … tree – Your smile for a greener environment
Molecular Imaging
Biograph mCT Flow TM and Symbia Intevo™
Would you like to have a tree growing in your name?
Take a pic at the RS booth at Arab Health and
support the ecoline Green Program.
For every picture published on our Wall of Fame
(, we will plant another
tree in Indonesia in your name.
Radiation Oncology
Imaging Solutions that empower Radiation Therapy.
Look closer. See further.
Siemens Healthcare provides tailored
imaging solutions that help Radiation
Therapy professionals to take treatment
decisions with confidence. With our
comprehensive portfolio – from CT
and CT Sliding Gantry, to MR, PET.CT and syngo.via – and our strategic
Partnership with Varian, we help advance cancer care.
Experience firsthand the clinical results from leading
institutions that are leveraging Biograph mCT FlowTM1
and Symbia IntevoTM1 to more confidently diagnose,
treat and monitor disease. And see how, together, we are
transforming the role of molecular imaging in patient care.
Biograph mCT Flow and Symbia Intevo are not commercially available in all countries.
Due to regulatory reasons their future availability cannot be guaranteed. Please contact your
local Siemens organization for further details.
Reading images on tablets is not for diagnostic use.
Magnetic Resonance
The clever spin on 1.5T: MAGNETOM Amira1 is
specifically designed to enhance clinical capabilities
and deliver comprehensive, advanced MRI technology.
It helps extend care to a greater number of patients,
improve the patient experience and boost process
efficiency – at lower costs per scan.
The product is currently under development; it is not for sale in the U.S. and other countries.
Its future availability cannot be guaranteed.
… at the Siemens Medlab booth RC10 in Sheikh Rashid Hall
ACUSON X600™ Ultrasound System
Discover the New Standard of “Standard.”
The ACUSON X600 system is engineered to punch above its
price class because some things – such as image quality and
reliability – should never be compromised. Its advanced
imaging engine, typically reserved for higher-end systems,
excels in General Imaging, Cardiology and OB/GYN.
ADVIA® Chemistry XPT System1 and
ADVIA Centaur® XPT Immunoassay System2
The ADVIA Chemistry XPT System and
the ADVIA Centaur XPT Immunoassay System
are engineered to provide quality results
with continuous operation to meet your
laboratory demands.
Imaging Software
syngo.via – the 3D and advanced visualization software
• Simple operations designed to improve workflow
• Efficient sample and reagent management for timely and accurate results
The new syngo.via1 supports a 360° view for treatment decisions
in oncology across modalities, therapies and departments. It comes
with a clear new UI and improved Patient Browser. The enhanced
syngo.via General Engine provides more anatomical presets, new
AutoViews and reporting features.
• Seamless connectivity to automation and IT to advance productivity
• Intuitive software that is easy to learn and easy to operate
Due to local regulations, not all products are available in all countries.
Not available for sale in the U.S. Due to local regulations, not all products are available
in all countries.
syngo.via can be used as a standalone device or together with a variety of syngo.via-based software options,
which are medical devices in their own right. syngo.via VB10 and the syngo.via VB10 based software options are
currently under development, and not for sale in the U.S., China and other countries. Due to regulatory reasons
its future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
Upper deck
Ground floor
Interventional Angiography
Artis with PURE®1
Increase your process efficiency
in the angio suite, enable all
your staff members to get the full
potential of the system, and
expand your clinical capabilities –
with an angio system that combines better ease
of use, integrated expert therapy guidance, and
tools providing better diagnostic information.
Xprecia Stride™ Coagulation Analyzer3
syngo® Lab Inventory Manager4
The Xprecia Stride™ Coagulation
Analyzer was designed specifically
to meet the needs of healthcare
professionals in usability, safety,
efficiency, and accuracy for confidence
in point-of-care testing.
syngo® Lab Inventory
Manager leverages webbased technology and
wireless radio frequency
identification to enable realtime, automated inventory management
and streamlined workflow across multiple
Not available for sale in the U.S. Product availability varies by country.
Artis with PURE® is pending 510(k) clearance, and is not yet
commercially available in the United States and other countries.
Computed Tomography
SOMATOM Definition Edge
Improve your institution’s process
efficiency and patient outcome by
exceeding expectations in all clinical
capabilities – from cardiology, to
optimized emergency care workflow,
and precise therapy response management in oncology.
“Exceeding expectations“ VS. “Accepting the average“
Second best is not an option.
Under development. Not available for sale. Future
availability cannot be guaranteed and may vary by country.
Aptio Automation5
Now with a “Tube Inspection Module” and
connectivity to the Sysmex® CS-5100 Hemostasis
System,6 Aptio™ Automation offers laboratories one
unified solution to help them meet expansion and
productivity goals. The new “Tube Inspection Module”
reduces pre-analytical errors by identifying incorrect tube labeling or
loading, and the integration of hemostasis streamlines workflow.
Product availability varies by country.
Not available for sale in the U.S. Sysmex is a trademark of the Sysmex Corporation.
Look closer.
With a single expert partner in breast ultrasound and mammography you can
achieve more than meets the eye.
Both ultrasound and mammography
provide advantages for breast imaging.
Combine them and you can reveal even
more. See what you can achieve with a
single expert partner: Our solutions offer
high-quality imaging. They smoothly
integrate in your clinical workflows. And
they let you access our global service
network. So take a closer look!
See clearly. Improve results and patient
outcomes. Obtain comprehensive clinical
information in 2D and 3D. And make
more confident decisions, even with
dense breast tissue.
Simplify operations. Make the most of
your team’s resources. Benefit from a
consistent user interface, an ergonomic
design, and integrated reading solutions
throughout breast imaging. For greater
efficiency every day.
Arab Health
Booth #S1D10,
Sheikh Saeed
Hall 1
Synergize business. Broaden your
revenue base and take advantage of a
powerful partnership. Offer reliable,
consistent, and comprehensive breast
imaging services. And substantially
increase your competitive edge.
Look closer with a single expert partner
in breast imaging. Look closer with
Answers for life.
Making healthcare pay off
Delivering high-quality diagnostic and interventional
services today can be quite a challenge. Yet this is how
your performance is measured by your stakeholders
every day. Keeping up with latest clinical developments,
access to investment funds, finding the right skill sets to
staff your teams, standardizing the quality of diagnostic
results across teams, efficient processes, reputation
building and risk management are many performance
dimensions that have been added over time to the core
of what you and your teams are tasked to support and
deliver: best patient outcome.
Scan to find
out more about
our presence
at Arab Health.
We at Siemens understand the demands you are
facing every day. That’s why we design value-based
innovations around you – making each day pay off
for your patients and for your business.
Visit us at booth S1D10, Sheikh Saeed Hall 1.
Answers for life.